BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7450929)

  • 1. Interaction of phenylbutazone and tolbutamide in man.
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction of phenylbutazone and tolbutamide in man].
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Orv Hetil; 1979 Nov; 120(47):2843-4. PubMed ID: 394087
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of salicyl compounds and other non-steroidal anti-inflammatory agents: pharmacokinetic study of phenylbutazone-aspirin combination in man].
    Gaucher A; Netter P; Faure G; Tamisier JN; Pourel J; Maillard A; Royer RJ
    Rev Rhum Mal Osteoartic; 1976 Jun; 43(6):425-9. PubMed ID: 781789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of interaction of tolbutamide and phenylbutazone in diabetic patients.
    Ober KF
    Eur J Clin Pharmacol; 1974 Jul; 7(4):291-4. PubMed ID: 4853129
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Phenylbutazone-tolbutamide drug interaction.
    Tannenbaum H; Anderson LG; Soeldner JS
    N Engl J Med; 1974 Feb; 290(6):344. PubMed ID: 4809290
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of phenylbutazone, tolbutamide and metabolites in plasma and urine using chemical ionization mass spectrometry.
    Weinkam RJ; Rowland M; Meffin PJ
    Biomed Mass Spectrom; 1977 Feb; 4(1):42-7. PubMed ID: 836942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological interference of glibornuride with sulfaphenazole, phenylbutazone, and phenprocoumon in man].
    Eckhardt W; Rudolph R; Sauer H; Schubert WR; Undeutsch D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2212. PubMed ID: 4679251
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Pharmacokinetic analysis of the dicumarol-tolbutamide interaction in man.
    Jähnchen E; Gilfrich HJ; Groth U; Meinertz T
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R88. PubMed ID: 49859
    [No Abstract]   [Full Text] [Related]  

  • 11. [Potentiation of tolbutamide by phenylbutazone].
    GULBRANDSEN R
    Tidsskr Nor Laegeforen; 1959 Oct; 79():1127-8. PubMed ID: 13830244
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacokinetics in liver cirrhosis].
    Ackermann E
    Z Gesamte Inn Med; 1977 Jan; 32(1):29-33. PubMed ID: 855389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of pargyline with tolbutamide in rabbits.
    Satyanarayana S; Krishna DM; Krishnaiah YS; Visweswaram D
    Indian J Physiol Pharmacol; 1995 Jan; 39(1):71-3. PubMed ID: 7705875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
    Kolenda KD; Grille W; Johnsen K
    Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of glymidine (glycodiazine) and tolbutamide in acute and chronic liver diseases.
    Held H; Eisert R; von Oldershausen HF
    Arzneimittelforschung; 1973 Dec; 23(12):1801-7. PubMed ID: 4801689
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of the hypoglycaemic action of tolbutamide by different drugs.
    Mahfouz M; Abdel-Maguid R; el-Dakhakhny M
    Arzneimittelforschung; 1970 Jan; 20(1):120-2. PubMed ID: 5467602
    [No Abstract]   [Full Text] [Related]  

  • 17. Ginkgo biloba extract modifies hypoglycemic action of tolbutamide via hepatic cytochrome P450 mediated mechanism in aged rats.
    Sugiyama T; Kubota Y; Shinozuka K; Yamada S; Wu J; Umegaki K
    Life Sci; 2004 Jul; 75(9):1113-22. PubMed ID: 15207658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interactions with oral sulphonylurea hypoglycaemic drugs.
    Hansen JM; Christensen LK
    Drugs; 1977 Jan; 13(1):24-34. PubMed ID: 401727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug interactions in therapy using coumarin derivatives].
    Gugler R
    Internist (Berl); 1979 May; 20(5):238-44. PubMed ID: 376479
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
    Veronich K; White G; Kapoor A
    J Pharm Sci; 1979 Dec; 68(12):1515-8. PubMed ID: 529041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.